Moderna, Inc.: Working Hard But Competition Is Working Harder
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
STAT4h
U.K. lawmaker wants regulators to probe pharma companies over ‘misleading’ Covid-19 vaccines statements
A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...
Moderna’s Shot Sales, Canceled Contract Lead to Another Loss
Moderna Inc. recorded a quarterly loss as vaccine sales waned and the company had an unexpected charge for a canceled ...
Fierce Biotech10h
Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
Mirage News2d
Engineer Applies Covid Lessons To Cancer
A chemical engineering professor at the University of Cincinnati is developing new ways to deliver treatments for infectious ...
The BMJ2d
Can WHO’s new trials guidance challenge a lack of inclusivity in research?
The World Health Organization wants to tackle inequity and bureaucracy relating to clinical trials. Will its latest guidance make a difference? Anna Volkmer reports During the covid-19 pandemic the UK ...
Senate votes to confirm Robert Kennedy as head of HHS
The Senate has voted to confirm the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Publicly traded ...
BabyCenter on MSN1d
Here's the vaccine schedule to follow for your baby or older child
Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...
Texas AG launches probe into controversial Chinese AI app DeepSeek: ‘Stealing the data of our citizens’
Texas Attorney General Ken Paxton has launched an investigation into DeepSeek, the upstart Chinese artificial intelligence ...
Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker.
Vaccine maker Moderna had no Valentine’s Day chocolates for investors when its financial results came out Friday. The company ...
US research hub at heart of brain drain for scientists returning to China, study finds
Cambridge, Massachusetts – home to Harvard and MIT – was the primary source of Chinese researchers who chose to head home.
Could Moderna’s (MRNA) 65% Stock Plunge Entice a Takeover?
Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...